Prestige BioPharma Revenue

Prestige BioPharma had revenue of 2.22B KRW in the quarter ending September 30, 2024, with 3,199.98% growth. This brings the company's revenue in the last twelve months to 2.84B, up 1,140.77% year-over-year. In the fiscal year ending June 30, 2024, Prestige BioPharma had annual revenue of 689.08M with 325.77% growth.

Revenue (ttm)

2.84B

Revenue Growth

+1,140.77%

P/S Ratio

n/a

Revenue / Employee

n/a

Employees

n/a

Market Cap

175.84B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	689.08M	527.23M	325.77%
Jun 30, 2023	161.84M	-	-
Jun 30, 2022	-	-	-
Jun 30, 2021	-	-	-
Jun 30, 2020	-	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Samsung Biologics	4,364.39B
Celltrion	2,876.25B
Yuhan	2,008.84B
SK Biopharmaceuticals	511.33B
SK bioscience	201.30B
Hanmi Pharm.	1,495.50B
Peptron	2.41B
Hanall Biopharma	134.24B

Revenue Rankings